Changing epidemiology of hepatitis C in Italy: a population-based survey in a historically high endemic area.


Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
Apr 2023
Historique:
medline: 3 5 2023
pubmed: 30 4 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

General population data on hepatitis C virus (HCV) prevalence in Italy come mostly from studies conducted in small towns. The highest rates have consistently been found in southern regions, especially in Calabria. Herein, we aimed to determine HCV prevalence, awareness, and risk factors in the general population of Catanzaro, the capital city of Calabria, Italy. A stratified probability-based random sample of adult population was drawn from the Census. Anti-HCV and HCV-RNA were assayed. Data on sociodemographycs, risk factors and awareness of infection status were also collected. Crude and age and sex directly standardized rates (DSR), using Catanzaro's general population as standard, were calculated. Log binomial regressions with sampling weights was used to identify independent predictors of infection. The final study population consisted of 1003 people. Of them 27 (2.69%; 95% confidence interval, [CI] 1.78-3.89) (DSR: 2.34%; 95% CI: 1.37-3.30) and 9 (0.9%; 95% CI: 0.41-1.70) (DSR: 0.79%; 95% CI: 0.21-1.37) were anti-HCV and HCV RNA positive, respectively. Most HCV-positive participants were older people. Age ≥65 and past use of illicit drugs were both positive independent predictors of anti-HCV positivity, while female sex was an independent protective predictor of infection. Only 9 (33.3%) of anti-HCV positive participants had awareness of their status. We detected a much lower anti-HCV prevalence than those previously found in Calabria, along with a substantial change in HCV transmission modes. Infected people were almost only elderly and mostly unaware of their infection. Improving diagnosis and linkage to care for these infected persons would be needed.

Sections du résumé

BACKGROUND BACKGROUND
General population data on hepatitis C virus (HCV) prevalence in Italy come mostly from studies conducted in small towns. The highest rates have consistently been found in southern regions, especially in Calabria. Herein, we aimed to determine HCV prevalence, awareness, and risk factors in the general population of Catanzaro, the capital city of Calabria, Italy.
METHODS METHODS
A stratified probability-based random sample of adult population was drawn from the Census. Anti-HCV and HCV-RNA were assayed. Data on sociodemographycs, risk factors and awareness of infection status were also collected. Crude and age and sex directly standardized rates (DSR), using Catanzaro's general population as standard, were calculated. Log binomial regressions with sampling weights was used to identify independent predictors of infection.
RESULTS RESULTS
The final study population consisted of 1003 people. Of them 27 (2.69%; 95% confidence interval, [CI] 1.78-3.89) (DSR: 2.34%; 95% CI: 1.37-3.30) and 9 (0.9%; 95% CI: 0.41-1.70) (DSR: 0.79%; 95% CI: 0.21-1.37) were anti-HCV and HCV RNA positive, respectively. Most HCV-positive participants were older people. Age ≥65 and past use of illicit drugs were both positive independent predictors of anti-HCV positivity, while female sex was an independent protective predictor of infection. Only 9 (33.3%) of anti-HCV positive participants had awareness of their status.
CONCLUSIONS CONCLUSIONS
We detected a much lower anti-HCV prevalence than those previously found in Calabria, along with a substantial change in HCV transmission modes. Infected people were almost only elderly and mostly unaware of their infection. Improving diagnosis and linkage to care for these infected persons would be needed.

Identifiants

pubmed: 33913660
pii: S0026-4806.21.07280-3
doi: 10.23736/S0026-4806.21.07280-3
doi:

Substances chimiques

RNA, Viral 0
Hepatitis C Antibodies 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-202

Investigateurs

Giorgio S Barreca (GS)
Roberto Bruni (R)
Paola Chionne (P)
Anna R Ciccaglione (AR)
Alfredo Focà (A)
Aida Giancotti (A)
Maria C Liberto (MC)
Giuseppe Lops (G)
Elisabetta Madonna (E)
Nadia Marascio (N)
Cinzia Marcantonio (C)
Antonio Martina (A)
Giovanni Matera (G)
Carolina Mirello (C)
Grazia Pavia (G)
Cinzia Peronace (C)
Patrizio Pezzotti (P)
Giulio Pisani (G)
Mariaconcetta Reale (M)
Giuseppe Guido (G)
Maria Scarlata (M)
Matteo Simeoni (M)
Enea Spada (E)
Carlo Torti (C)
Elena Tritarelli (E)
Maria F Vescio (MF)
Umbertina Villano (U)

Auteurs

Enea Spada (E)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy - enea.spada@iss.it.

Cinzia Marcantonio (C)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Maria F Vescio (MF)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Nadia Marascio (N)

Department of Health Sciences, "Magna Graecia" University, Catanzaro, Italy.

Umbertina Villano (U)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Giulio Pisani (G)

National Center for the Control and Evaluation of Medicines, Istituto Superiore di Sanità (ISS), Rome, Italy.

Elena Tritarelli (E)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Roberto Bruni (R)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Giorgio S Barreca (GS)

Department of Health Sciences, "Magna Graecia" University, Catanzaro, Italy.

Carlo Torti (C)

Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.

Giovanni Matera (G)

Department of Health Sciences, "Magna Graecia" University, Catanzaro, Italy.

Maria C Liberto (MC)

Department of Health Sciences, "Magna Graecia" University, Catanzaro, Italy.

Alfredo Focà (A)

Department of Health Sciences, "Magna Graecia" University, Catanzaro, Italy.

Patrizio Pezzotti (P)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Anna Rita Ciccaglione (AR)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH